Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Itti

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
European Radiology|March 10, 2015
Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom studyEdouard Hérin, François Gardavaud, Mélanie Chiaradia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT studyFlorent Hugonnet, Laure Fournier, Jacques Medioni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference backgroundEmmanuel Itti, Malik E Juweid, Corinne Haioun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2014
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patientsMichel Meignan, Myriam Sasanelli, René Olivier Casasnovas, et al.
Best Practice & Research. Clinical Rheumatology|June 18, 2019
Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging featuresMehdi Aoun Sebaiti, Marie Abrivard, Paul Blanc-Durand, et al.
AJR. American Journal of Roentgenology|September 8, 2021
Utility of Early Posttreatment PET/CT Evaluation Using FDG or <sup>18</sup>F-FCH to Predict Response to <sup>90</sup>Y Radioembolization in Patients With Hepatocellular CarcinomaEdouard Reizine, Julia Chalaye, Sebastien Mule, et al.
Leukemia & Lymphoma|March 7, 2014
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient managementJulia Chalaye, Alain Luciani, Catalina Enache, et al.
Medicine|September 28, 2017
Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case reportAxel Van Der Gucht, Mukedaisi Abulizi, Paul Blanc-Durand, et al.
European Radiology|November 29, 2021
Optimization of whole-body 2-[<sup>18</sup>F]FDG-PET/MRI imaging protocol for the initial staging of patients with myelomaRobert Burns, Sébastien Mulé, Paul Blanc-Durand, et al.
Radiology|February 27, 2009
Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experienceChieh Lin, Alain Luciani, Karim Belhadj, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
European Radiology|March 10, 2015
Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom studyEdouard Hérin, François Gardavaud, Mélanie Chiaradia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT studyFlorent Hugonnet, Laure Fournier, Jacques Medioni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference backgroundEmmanuel Itti, Malik E Juweid, Corinne Haioun, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2014
Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patientsMichel Meignan, Myriam Sasanelli, René Olivier Casasnovas, et al.
Best Practice & Research. Clinical Rheumatology|June 18, 2019
Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging featuresMehdi Aoun Sebaiti, Marie Abrivard, Paul Blanc-Durand, et al.
AJR. American Journal of Roentgenology|September 8, 2021
Utility of Early Posttreatment PET/CT Evaluation Using FDG or <sup>18</sup>F-FCH to Predict Response to <sup>90</sup>Y Radioembolization in Patients With Hepatocellular CarcinomaEdouard Reizine, Julia Chalaye, Sebastien Mule, et al.
Leukemia & Lymphoma|March 7, 2014
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient managementJulia Chalaye, Alain Luciani, Catalina Enache, et al.
Medicine|September 28, 2017
Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case reportAxel Van Der Gucht, Mukedaisi Abulizi, Paul Blanc-Durand, et al.
European Radiology|November 29, 2021
Optimization of whole-body 2-[<sup>18</sup>F]FDG-PET/MRI imaging protocol for the initial staging of patients with myelomaRobert Burns, Sébastien Mulé, Paul Blanc-Durand, et al.
Radiology|February 27, 2009
Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experienceChieh Lin, Alain Luciani, Karim Belhadj, et al.
Pageof 15